Rab11 in dysplasia of Barrett's epithelia

Yale Journal of Biology and Medicine

Volumn 72, Issue 2-3, 1999, Pages 113-120

  Goldenring, James R ^a,b   Ray, Gregory S ^a   Lee, Jeffrey R ^a  

^a Institute of Molecular Medicine and Genetics   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER CELL; DISEASE PREDISPOSITION; DYSPLASIA; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HUMAN; REFLUX ESOPHAGITIS; REVIEW;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY; EPITHELIUM; ESOPHAGEAL NEOPLASMS; HUMANS; PRECANCEROUS CONDITIONS; RAB GTP-BINDING PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; STAINING AND LABELING; TUMOR CELLS, CULTURED;

EID: 0033492332     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Altorki, N., Schwartz, G., Blundell, M., Davis, B., Kelsen, D., and Albino, A. Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Cance. 72: 649-657, 1993.
2. Blount, P.L., Galipeau, P.C., Sanchez, C.A., Neshat, K., Levine, D.S., Yin, J., Suzuki, H., Abraham, J.M., Meltzer, S.J., and Reid, B.J. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res. 54:2292-2295, 1994.
3. Blount, P.L., Ramel, S., Raskind, W.H., Haggitt, R.C., Sanchez, C.A., Dean, P.J., Rabinovitch, P.S., and Reid, B.J. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res. 51:5482-5486, 1991.
4. Calhoun, B.C. and Goldenring, J.R. Two Rab proteins, VAMP-2, and SCAMPs are present on immunoisolated gastric tubulovesicles. Biochem. J. 325:559-564, 1997.
5. Casson, A.G., Manolopoulos, B., Troster, M., Kerkvliet, N., O'Malley, F., Inculet, R., Finley, R., and Roth, J.A. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. Am. J. Surg. 167:52-57, 1994.
6. Flejou, J-F., Potet, F., Muzeau, F., Le Pelletier, F., Fekete, F., and Henin, D. Overexpression of p53 protein in Barrett's syndrome with malignant transformation. J. Clin. Pathol. 46:330-333, 1993.
7. Goldenring, J.R., Bhartur, S., Navarre, F., Wang, X., and Casanova, J. Rab11 and Rab25 localize to the apical recycling system in MDCK cells. Mol. Biol. Cell. 8:408a, 1997.
8. Goldenring, J.R., Smith, J., Vaughan, H.D., Cameron, P., Hawkins, W., and Navarre, J. Rab11 is an apically located small GTP-binding protein in epithelial tissues. Am. J. Physiol. 270(33):G515-G525, 1996.
9. Goldenring, J.R., Soroka, C.J., Shen, K.R., Tang, T.H., Rodriguez, W., Vaughan, H.D., Stoch, S.A., and Modlin, I.M. Enrichment of rab11, a small GTP-binding protein, in gastric parietal cells. Am. J. Physiol. 267: G187-G194, 1994.
10. Green, E.G., Ramm, E., Riley, N.M., Spiro, D.J., Goldenring, J.R., and Wessling-Resnick, M. Rab11 is associated with transferrin-containing recycling compartments in K562 cells. Biochem. Biophys. Res. Commun. 239:612-616, 1997.
11. Haggitt, R.C. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum. Pathol. 25:982-993, 1994.
12. Hameeteman, W., Tytgat, G.N.J., Houthoff, H.J., and Van Den Tweel, J.G. Barren's esophagus: devlopment of dysplasia and adenocarcinoma. Gastroenterology 96:1249-1256, 1989.
13. Hamelin, R., Flejou, J.F., Muzeau, F., Potet, F., Laurent-Puig, P., Fekete, F., and Thomas, G. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology 107:1012-1018, 1994.
14. Hamilton, S.R., Smith, R.R.L., and Cameron, J.L. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum. Pathol. 19:942-948, 1988.
15. Hardwick, R.H., Shepherd, N.A., Moorghen, M., Newcomb, P.V., and Alderson, D. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut 35:764-768, 1994.
16. Iftikhar, S.Y, James, P.D., Steele, R.J.C., Hardcastle, J.D., and Atkinson, M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 33:1155-1158, 1992.
17. Isolauri, J. and Laippala, P. Prevalence of symptoms suggestive of gastro-esophageal reflux disease in an adult population. Ann. Med. 27:67-70, 1995.
18. Jones, D.R., Davidson, A.G., Summers. C.L., Murray, G.F., and Quinlan, D.C. Potential application of p53 as an intermediate biomarker in Barren's esophagus. Ann. Thorac. Surg. 57:598-603, 1994.
19. Krishnadath, K.K., Tilanus, H.W., and van Blankenstein, M. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J. Pathol. 175:175-180, 1995.
20. Levine, D.S., Reid, B.J., Haggitt, R.C., Rubin, C.E., and Rabinovitch, P.S. Correlation of ultrastructural alterations with dysplasia and flow cytometric abnormalities in Barrett's epithelium. Gastroenterology. 96:355-367, 1989.
21. Levine, D.S., Rubin, C.E., Reid, B.J., and Haggitt, R.C. Specialized metaplastic columnar epithelium in Barrett's esophagus: a comparative transmission electron microscopic study. Lab. Invest. 60:418-431, 1989.
22. Meltzer, S.J., Yin, J., Manin, B., Rhyu, M.-G., Cottrell, J., Hudson, E., Redd, J.L., Krasna, M.J, Abraham, J.M., and Reid, B.J. Microsatellite instability occurs freqently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res. 54:3379-3382, 1994.
23. Miros, M., Kerlin, P., and Walker, N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 32: 1441-1446, 1991.
24. Moskalluk, C.A., Heitmiller, R., Zahurak, M., Schwab, D., Sidransky, D., and Hamilton, S.R. p53 and p21WAF1/CIP1/ SDI1 gene products in Barrett's esophagus and adenocarcinoma of the esophagus and esophagogastric junction. Hum. Pathol. 27:1211-1220, 1996.
25. Neshat, K., Sanchez, C.A., Galipeau, P.C., Blount, P.L., Levine, D.S., Joslyn, G., and Reid, B.J. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 106:1589-1595, 1994.
26. Nishimaki, T., Holscher, A.H., Schuler, M., Bollschweiler, E., Becker. K., and Siewert, J.R. Histopathologic characteristics of early adenocarcinoma in Barrett's esophagus. Cancer 68:1731-1736, 1991.
27. Ovaska, J., Miettinen, M., and Kivilaakso, E. Adenocarcinoma arising in Barrett's esophagus. Dig. Dis. Sci. 34:1336-1339, 1989.
28. Provenzale, D., Kemp, J.A., Arora, S., and Wong, J.B. A guide for surveillance of patients with Barrett's esophagus. Am. J. Gastroenterol. 89:670-680, 1994.
29. Raiha, I.J., Impivaara, O., Seppala, M., and Sourander, L.B. Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly. J. Am. Geriat. Soc. 40:1209-1211, 1992.
30. Ray, G.S., Lee, J.R., Nwokeji, K, Mills, L.R., and Goldenring, J.R. Increased immunoreactivity for Rab11, a small GTP-binding protein, in low-grade dysplastic Barrett's epithelia. Lab. Invest. 77:503-511, 1997.
31. Reid, B.J. Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol. Clin. North Am. 20:817-834, 1991.
32. Reid, B.J., Blount, P.L., Rubin, C.E., Levine, D.S., Haggitt, R.C., and Rabinovitch, P.S. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort. Gastroenterology. 102:1212-1219, 1992.
33. Reid, B.J., Haggitt, R.C., Rubin, C.E., and Rabinovitch, P.S. Barrett's esophagus: Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93:1-11, 1987.
34. Reid, B.J., Haggitt, R.C., Rubin, C.E., Roth, G., Surawicz, C.M., Van Belle, G., Lewin, K., Weinstein, W.M., Antonioli, D.A., Goldman, H., MacDonald, W., and Owen, D. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum. Pathol. 19:166-178, 1988.
35. Rice, T.W., Goldblum, J.R., and Falk, G.W. P53 immunoreactivity in Barrett's metaplasia, dysplasia and carcinoma. J. Thorac. Cardiovasc. Surg. 108:1132-1137, 1994.
36. Riddell, R.H., Goldman, H., Ransohoff, D.F., Appelmann, H.D., Fenoglio, C.M., Haggitt, R.C., Ahren, C., Correa, P., Hamilton, S.R., Morson, B.C., Sommers, S.C., and Yardley, J.H. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol. 14:931-967, 1983.
37. Robertson, C.S., Mayberry, J.F., Nicholson, D.A., James, P.D., and Atkinson, M. Value of endoscopie surveillance in the detection of neoplastic change in Barrett's oesophagus. Br. J. Surg. 75:760-763, 1988.
38. Sorsdahl, K., Casson, A.G., Troster, M., Meyel, D.V., Inculet, R., and Chamber, A.F. p53 and ras gene espression in human esophageal cancer and Barrett's epithelium: A prospective study. Cancer Detect. Prevent. 18:179-185, 1994.
39. Spechler, S.J. and Goyal, R.K. Barrett's esophagus. New Engl. J. Med. 315:362-371, 1986.
40. Starnes, V.A., Adkins, R.B., Ballinger, J.F., and Sawyers, J.L. Barrett's Esophagus: A surgical entity. Arch. Surg. 119:563-567, 1984.
41. Thompson, J.J., Zinsser, K.R., and Enterline, H.T. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum. Pathol. 14:42-61, 1983.
42. Ullrich, O., Reinsch, S., Urbe, S., Zerial, M., and Parton, R.G. Rab11 regulates recycling through the pericentriolar recycling endosome. J. Cell Biol. 135:913-924, 1996.
43. Younes, M., Lebovitz, R.M., Lechago, R.M., and Lechago, J. p53 protein accumulation in Barrett's metaplasia, dysplasia and carcinoma: a follow-up study. Gastroenterology 105:1637-1642, 1993.